Factor IXa inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 7, 2017
Issued Date -
Feb 2, 2017
app pub date -
Apr 10, 2015
filing date -
Apr 16, 2014
priority date (Note) -
Published
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
In its many embodiments, the present invention provides a novel class of benzamide compounds represented by Formula (I) or pharmaceutically acceptable salts or solvates thereof, or pharmaceutical compositions comprising one or more said compounds or pharmaceutically acceptable salts or solvates thereof, and methods for using said compounds or pharmaceutically acceptable salts or solvates thereof for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes.
First Claim
Other Claims data not available
Family
Loading Family data...
International Classification(s)
- 2015 Application Filing Year
- A61K Class
- 16157 Applications Filed
- 11882 Patents Issued To-Date
- 73.55 % Issued To-Date
Cited Art Landscape
Patent Citation Ranking
- 0 Citation Count
- A61K Class
- 0 % this patent is cited more than
- 8 Age
Maintenance Fees
| Fee | Large entity fee | small entity fee | micro entity fee | due date |
|---|---|---|---|---|
| 7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | May 7, 2025 |
| 11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | May 7, 2029 |
